Clinical Trials Identifier : NCT02234050
Updated : 2017_02_06.
Descriptive Information :
Brief title :
Trabectedin for Recurrent Grade II/III Meningioma .
Official title :
Trabectedin for Recurrent Grade II or III Meningioma: a Randomized Phase II Study of the EORTC Brain Tumor Group
The aim of this study is to collect data on activity, toxicity and quality of life of Trabectedin therapy in patients with recurrent high-grade Meningioma.
Recruitment Information :
Status Recruiting :
Start date : 2015-07 .
Primary completion date 2017-07 (Anticipated) .
Administrative Data :
Organization Name : European Organisation for Research and Treatment of Cancer - EORTC .